Rights and permissions
About this article
Cite this article
Infliximab prior to adalimumab creates good QOL gains in CD. Pharmacoecon. Outcomes News 619, 10 (2011). https://doi.org/10.2165/00151234-201106190-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106190-00031